Abstract
Fibroblastic rheumatism (FR) is an uncommon disease of the skin, characterized by the presence of non-tender cutaneous nodules accompanied often by other rheumatic manifestations. This condition shows male predominance, no age preference and unpredictable course, resulting frequently in permanent joint damage. A 60-year-old man came to our department with a 4-year history of multiple non-tender nodules and morning stiffness affecting mainly the upper extremities. Clinical examination revealed arthritis of the hands, confirmed by imaging tests. Laboratory exams were unremarkable. A skin nodule biopsy showed a dermal collagenous lesion with myxoid areas composed of spindle and stellate cells. Immunohistochemical staining demonstrated positivity for CD68 and negativity for CD34, S100, EMA and desmine. FR was diagnosed and the patient started methylprednisolone 16 mg/day. Hydroxychloroquine 400 mg/day and methotrexate 15 mg/weekly were further added as steroid-sparing agents with clinical benefit. Clinicians should be aware of this underreported entity, which can rapidly lead to irreversible deformities.
Similar content being viewed by others
References
Chaquat Y, Aron-Brunetiere R, Faures B et al (1980) Une nouvelle entite: Ie rhumatis me fibroblastique. A propos d’une observation. Rev Rhum Mal Osteoartic 47:345–351
Jurado SA, Alvin GK, Selim MA et al (2012) Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications. J Am Acad Dermatol 66(6):959–965. https://doi.org/10.1016/j.jaad.2011.07.013
Lee JM, Sundel RP, Liang MG (2002) Fibroblastic rheumatism: case report and review of the literature. Pediatr Dermatol 19(6):532–535. https://doi.org/10.1046/j.1525-1470.2002.00227.x
Vittecoq O, Mejjad O, da Silva F et al (1996) Preliminary experience with low-dose methotrexate in fibroblastic rheumatism. Arthritis Rheum 39(12):2070–2073. https://doi.org/10.1002/art.1780391218
Romas E, Finlay M, Woodruff T (1997) The arthropathy of fibroblastic rheumatism. Arthritis Rheum 40(1):183–187. https://doi.org/10.1002/art.1780400124
Suri R, Azzam MJ, Heaphy MR Jr (2020) Firm cutaneous nodule on the dorsal hand: a case report on fibroblastic rheumatism. Cureus 12(9):e10312. https://doi.org/10.7759/cureus.10312
Zou XW, Huo J, Wang JM et al (2015) Fibroblastic rheumatism: the first case with infiltration of multinuclear giant cells and raised blood lead level. Clin Exp Dermatol 40(3):309–312. https://doi.org/10.1111/ced.12542
Luchsinger I, Coulombe J, Rongioletti F et al (2018) Self-healing juvenile cutaneous mucinosis: clinical and histopathologic findings of 9 patients: the relevance of long-term follow-up. J Am Acad Dermatol 78(6):1164–1170. https://doi.org/10.1016/j.jaad.2017.10.023
Ostlere LS, Stevens HP, Jarmulowicz M et al (1994) Fibroblastic rheumatism. Clin Exp Dermatol 19(3):268–270. https://doi.org/10.1111/j.1365-2230.1994.tb01185.x
Romiti R, Levy Neto M, Menta Simonsen Nico M (2009) Response of fibroblastic rheumatism to infliximab. Dermatol Res Pract 2009:715729. https://doi.org/10.1155/2009/715729
Watanabe S, Kamada K, Imai H et al (2010) An Asian case of fibroblastic rheumatism: clinical, radiological, and histological features. Mod Rheumatol 20(4):423–426. https://doi.org/10.1007/s10165-010-0297-3
Ji L, Geng Y, Hao Y et al (2011) Fibroblastic rheumatism: an addition to fibromatosis. Joint Bone Spine 78(5):519–521. https://doi.org/10.1016/j.jbspin.2011.03.008
Cai SCS, Tee SI, Lee JSS et al (2020) Fibroblastic rheumatism versus variant disease of multinucleate cell angiohistiocytoma. Am J Dermatopathol 42(2):136–139. https://doi.org/10.1097/DAD.0000000000001550
Hernandez RJ, Headington JT, Kaufman RA et al (1989) Case report 511. Skeletal Radiol 18:43–45. https://doi.org/10.1007/BF00366771
Kanzler MH, Dhillon I, Headington JT (1995) Fibroblastic rheumatism. Arch Dermatol 131(6):710–712
Feldon M, Sikora K, Huggins JL et al (2016) Polyarticular arthritis and skin nodulosis in a 14-year-old female. Arthritis Care Res 68:700–705
Chkirate B, Job-Deslandre C (2001) Rhumatisme fibroblastique: à propos d’un cas [fibroblastic rheumatism: a case report]. Arch Pediatr 8(4):389–392. https://doi.org/10.1016/s0929-693x(00)00216-5
Kluger N, Dumas-Tesici A, Hamel D et al (2010) Fibroblastic rheumatism: fibromatosis rather than non-Langerhans cell histiocytosis. J Cutan Pathol 37(5):587–592. https://doi.org/10.1111/j.1600-0560.2009.01345.x
Schiavon F, Punzi L, Todesco S (1998) Fibroblastic rheumatism: a fifteen-year followup study. Arthritis Rheum 41(4):759–760. https://doi.org/10.1002/1529-0131(199804)41:4%3c759::AID-ART39%3e3.0.CO;2-Y
Vignon-Pennamen MD, Naveau B, Foldes C et al (1986) Fibroblastic rheumatism. J Am Acad Dermatol 14(6):1086–1088. https://doi.org/10.1016/s0190-9622(86)80186-4
Lacour JP, Maquart FX, Bellon G et al (1993) Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol 128(2):194–202. https://doi.org/10.1111/j.1365-2133.1993.tb15151.x
Colonna L, Barbieri C, Di Lella G et al (2002) Fibroblastic rheumatism: a case without rheumatological symptoms. Acta Derm Venereol 82(3):200–203. https://doi.org/10.1080/00015550260132505
Pedersen JK, Poulsen T, Hørslev-Petersen K (2005) Fibroblastic rheumatism: a Scandinavian case report. Ann Rheum Dis 64(1):156–157. https://doi.org/10.1136/ard.2003.008441
Réty F, Tayebjee OA, Servettaz A et al (2007) Radiological bone lesions in fibroblastic rheumatism; case report. Presse Med 36(3 Pt 1):432–436. https://doi.org/10.1016/j.lpm.2006.11.010
Muñoz A, Conde JM, Rejon E, Marenco JL (2012) Reumatismo fibroblástico. Estudio de un paciente [Fibroblastic rheumatism. Case report]. Med Clin (Barc) 138(1):44–45. https://doi.org/10.1016/j.medcli.2011.04.006
Cabral R, Brinca A, Cardoso JC et al (2013) Fibroblastic rheumatism—case report. Acta Reumatol Port 38(2):128–130
Courties A, Guégan S, Miquel A et al (2014) Fibroblastic rheumatism: immunosuppressive therapy is not always required. Joint Bone Spine 81(2):178–179. https://doi.org/10.1016/j.jbspin.2013.06.012
du Toit R, Schneider JW, Whitelaw DA (2006) Fibroblastic rheumatism. J Clin Rheumatol 12(4):201–203. https://doi.org/10.1097/01.rhu.0000231383.50323.b5
Marconi IM, Rivitti-Machado MC, Sotto MN et al (2009) Fibroblastic rheumatism. Clin Exp Dermatol 34(1):29–32. https://doi.org/10.1111/j.1365-2230.2008.02748.x
Paupitz JA, de Carvalho JF (2012) Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism. Rheumatol Int 32(6):1789–1791. https://doi.org/10.1007/s00296-010-1433-2
Parida JR, Agarwal V, Krishnani N (2012) An unusual case of polyarthritis, skin nodules and patchy skin thickening: fibroblastic rheumatism. Int J Rheum Dis 15(1):e12–e14. https://doi.org/10.1111/j.1756-185X.2011.01661.x
Motegi SI, Yamazaki S, Fujiwara C et al (2018) Fibroblastic rheumatism: a case of multiple nodules of fingers and hands, contractures of fingers and polyarthritis. J Dermatol 45(6):e142–e143. https://doi.org/10.1111/1346-8138
Lanni C, Bottone MG, Bardoni A et al (2003) Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism. Eur J Histochem 47(3):257–262
Trotta F, Colina M (2012) Multicentric reticulohistiocytosis and fibroblastic rheumatism. Best Pract Res Clin Rheumatol 26(4):543–557. https://doi.org/10.1016/j.berh.2012.07.006
Helm TN, Helme KF (1998) Histiocytes and fibroblastic rheumatism: comment on the article by Romas et al. Arthritis Rheum 41(2):379
Author information
Authors and Affiliations
Contributions
All authors contributed to the final manuscript. PVV, AIV, PA and ZA: literature screening, case reporting, manuscript preparation. SA: case reporting and literature screening. AAD: review, editing, and supporting. All authors have read and approved the final submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors (Pieta A, Zioga A, Skalkou A, Venetsanopoulou AI, Drosos AA, Voulgari PV) have no conflict of interest.
Ethics approval
This study was conducted in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
The patient gave written informed consent before clinical data collection.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pieta, A., Zioga, A., Skalkou, A. et al. Fibroblastic rheumatism: an uncommon arthritis. A case-based review. Rheumatol Int 42, 1097–1103 (2022). https://doi.org/10.1007/s00296-021-05004-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-05004-0